ArticleCureus2026
Epithelial Downgrowth Mixed With Fibrous Ingrowth After Complicated Cataract Surgery: A Challenging Clinical Case.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epithelial downgrowth (ED) is a rare but dreaded complication of intraocular surgery or trauma and is characterized by the intraocular migration or seeding of epithelial cells from the ocular surface, sometimes with concurrent intraocular proliferation of fibrovascular tissue. Due to its insidious development, it may present diagnostic difficulties to the ophthalmologist; moreover, its relentless progression poses a tough therapeutic challenge with a generally poor visual prognosis. In this paper, we describe the case of a 68-year-old man who developed mixed ED and fibrous ingrowth (FI) after complicated cataract surgery. His clinical picture was initially misdiagnosed and treated as malignant glaucoma with only a brief period of improvement. Surgical removal of a specimen of the pathologic intraocular tissue, followed by its cytological analysis, confirmed the diagnosis. Due to intractably high intraocular pressure (IOP) and persistent corneal edema, we proceeded to glaucoma shunt implantation and subsequently to full-thickness corneal transplantation. Eighteen months after the keratoplasty, the patient fares well with a reasonably good vision of 20/30, a clear corneal graft, and no signs of downgrowth recurrence. This case illustrates the diagnostic and therapeutic challenges posed by ED but also the importance of its multidisciplinary management in order to achieve the best possible visual outcome for the patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.